113 related articles for article (PubMed ID: 38846818)
1. Network pharmacology prediction and experiment validation of anti-liver cancer activity of Curcumae Rhizoma and Hedyotis diffusa Willd.
Tie S; Tong T; Zhan G; Li X; Ouyang D; Cao J
Ann Med Surg (Lond); 2024 Jun; 86(6):3337-3348. PubMed ID: 38846818
[TBL] [Abstract][Full Text] [Related]
2. Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking.
Ren J; Mo Z; Huang Z; Li S
Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38638040
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental validation to identify the potential mechanism of Hedyotis diffusa Willd against rheumatoid arthritis.
Deng H; Jiang J; Zhang S; Wu L; Zhang Q; Sun W
Sci Rep; 2023 Jan; 13(1):1425. PubMed ID: 36697436
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer.
Yuan X; Huang H; Yu C; Tang Z; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38446216
[TBL] [Abstract][Full Text] [Related]
5. [Anti-colorectal cancer mechanism of Astragali Radix-Curcumae Rhizoma-Paridis Rhizoma based on network pharmacology and experimental verification].
Liang Y; Sun RL; Liu FY; Liu TT; Guan HQ; Tang DC
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):776-785. PubMed ID: 35178961
[TBL] [Abstract][Full Text] [Related]
6. Bioactive constituents and the molecular mechanism of Curcumae Rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking.
Tong H; Yu M; Fei C; Ji D; Dong J; Su L; Gu W; Mao C; Li L; Bian Z; Lu T; Hao M; Zeng B
Phytomedicine; 2021 Jun; 86():153558. PubMed ID: 33866197
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanism of action of Hedyotis diffusa Willd on acne using network analysis.
Seo G; Kim K
Medicine (Baltimore); 2023 Mar; 102(12):e33323. PubMed ID: 36961163
[TBL] [Abstract][Full Text] [Related]
8. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis.
Ye C; Zhang B; Tang Z; Zheng C; Wang Q; Tong X
Int Immunopharmacol; 2024 May; 132():111866. PubMed ID: 38603854
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
Bai Y; Chen R; Sun J; Guo Y
Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hedyotis diffusa Willd-specific mRNA-miRNA-lncRNA network in rheumatoid arthritis based on network pharmacology, bioinformatics analysis, and experimental verification.
Jiang J; Huang M; Zhang SS; Wu YG; Li XL; Deng H; Qili XY; Chen JL; Meng Y; Sun WK
Sci Rep; 2024 Mar; 14(1):6291. PubMed ID: 38491124
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
12. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
13. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis.
Zhuang Y; Sun YG; Wang CG; Zhang Q; Che C; Shao F
Curr Drug Targets; 2024 Jan; ():. PubMed ID: 38213161
[TBL] [Abstract][Full Text] [Related]
14. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
[TBL] [Abstract][Full Text] [Related]
16. Active ingredients screening and pharmacological mechanism research of curcumae rhizoma-sparganii rhizoma herb pair ameliorates liver fibrosis based on network pharmacology.
Hao M; Yao Z; Zhao M; Chen Z; Wang P; Sang X; Yang Q; Wang K; Han X; Cao G
J Ethnopharmacol; 2023 Apr; 305():116111. PubMed ID: 36592822
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology-Based Approach to Investigate the Mechanisms of
Liu X; Wu J; Zhang D; Wang K; Duan X; Meng Z; Zhang X
Evid Based Complement Alternat Med; 2018; 2018():7802639. PubMed ID: 29853970
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effects of Hedyotis diffusa Willd on SLE with STAT3 as a key target.
Xu L; Li Y; Ji J; Lai Y; Chen J; Ding T; Li H; Ding B; Ge W
J Ethnopharmacol; 2022 Nov; 298():115597. PubMed ID: 35940466
[TBL] [Abstract][Full Text] [Related]
19. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
[TBL] [Abstract][Full Text] [Related]
20. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
